FLECAINIDE ACETATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for flecainide acetate and what is the scope of freedom to operate?

Flecainide acetate is the generic ingredient in two branded drugs marketed by Amneal Pharm, Ani Pharms, Aurobindo Pharma Ltd, Beximco Pharms Usa, Chartwell, Hikma, Sun Pharm Inds Ltd, Yichang Humanwell, and Alvogen, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for flecainide acetate. Fifteen suppliers are listed for this compound.

Summary for FLECAINIDE ACETATE

US Patents:	0
Tradenames:	2
Applicants:	9
NDAs:	10
Drug Master File Entries:	10
Finished Product Suppliers / Packagers:	15
Raw Ingredient (Bulk) Api Vendors:	79
Clinical Trials:	5
Patent Applications:	1,148
Drug Prices:	Drug price trends for FLECAINIDE ACETATE
What excipients (inactive ingredients) are in FLECAINIDE ACETATE?	FLECAINIDE ACETATE excipients list
DailyMed Link:	FLECAINIDE ACETATE at DailyMed

See drug prices for FLECAINIDE ACETATE

Recent Clinical Trials for FLECAINIDE ACETATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
InCarda Therapeutics, Inc.	Phase 3
InCarda Therapeutics, Inc.	Phase 2
InCarda Therapeutics Australia Pty Ltd.	Phase 2

See all FLECAINIDE ACETATE clinical trials

Pharmacology for FLECAINIDE ACETATE

Drug Class	Antiarrhythmic

Medical Subject Heading (MeSH) Categories for FLECAINIDE ACETATE

Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers

Anatomical Therapeutic Chemical (ATC) Classes for FLECAINIDE ACETATE

C01BC	Antiarrhythmics, class Ic
C01B	ANTIARRHYTHMICS, CLASS I AND III
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for FLECAINIDE ACETATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Ltd	FLECAINIDE ACETATE	flecainide acetate	TABLET;ORAL	076421-003	Mar 28, 2003	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Beximco Pharms Usa	FLECAINIDE ACETATE	flecainide acetate	TABLET;ORAL	210683-001	Sep 16, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Beximco Pharms Usa	FLECAINIDE ACETATE	flecainide acetate	TABLET;ORAL	210683-002	Sep 16, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ani Pharms	FLECAINIDE ACETATE	flecainide acetate	TABLET;ORAL	076030-002	Oct 28, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for FLECAINIDE ACETATE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-002	Oct 31, 1985	⤷ Sign Up	⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-001	Oct 31, 1985	⤷ Sign Up	⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-003	Jun 3, 1988	⤷ Sign Up	⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-002	Oct 31, 1985	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.